118 related articles for article (PubMed ID: 12530060)
1. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Hopfner R; Mousli M; Oudet P; Bronner C
Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
[TBL] [Abstract][Full Text] [Related]
2. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
3. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
Isaacs RJ; Harris AL; Hickson ID
J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
[TBL] [Abstract][Full Text] [Related]
9. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
10. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
[TBL] [Abstract][Full Text] [Related]
11. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
Unoki M; Nishidate T; Nakamura Y
Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of ICBP90 contributes to doxorubicin resistance.
Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
[TBL] [Abstract][Full Text] [Related]
13. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity.
Un F; Qi C; Prosser M; Wang N; Zhou B; Bronner C; Yen Y
Anticancer Res; 2006; 26(4B):2761-7. PubMed ID: 16886595
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
[TBL] [Abstract][Full Text] [Related]
15. Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.
Yoon JH; Kim JK; Rha GB; Oh M; Park SH; Seong RH; Hong SH; Park SD
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):367-74. PubMed ID: 10567217
[TBL] [Abstract][Full Text] [Related]
16. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
[TBL] [Abstract][Full Text] [Related]
17. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.
Achour M; Jacq X; Rondé P; Alhosin M; Charlot C; Chataigneau T; Jeanblanc M; Macaluso M; Giordano A; Hughes AD; Schini-Kerth VB; Bronner C
Oncogene; 2008 Apr; 27(15):2187-97. PubMed ID: 17934516
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human topoisomerase IIalpha gene.
Bronner C; Hopfner R; Mousli M
Anticancer Res; 2002; 22(2A):605-12. PubMed ID: 12014628
[TBL] [Abstract][Full Text] [Related]
19. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
